Appropriate methods to monitor controlled ovarian hyperstimulation?
Cebesoy
Fatma Bahar
FB
D004334:Drug Administration Schedule; D004717:Endometrium / Q000187:drug effects*; D005260:Female; D005300:Fertility Agents, Female / Q000008:administration & dosage*; D005307:Fertilization in Vitro; D007987:Gonadotropin-Releasing Hormone / Q000819:agonists / Q000037:antagonists & inhibitors / Q000378:metabolism; D006727:Hormone Antagonists / Q000008:administration & dosage; D006801:Humans; D007246:Infertility / Q000378:metabolism / Q000628:therapy*; D010062:Ovulation Induction / Q000379:methods*; D018579:Patient Selection; D016896:Treatment Outcome
D005300:Fertility Agents, Female; D006727:Hormone Antagonists; D007987:Gonadotropin-Releasing Hormone